Delivery Order SPE2DB22D2108-SPE2DB24FU3GV
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. This $6,046.50 firm fixed price contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds an indefinite delivery contract (IDC) with DLA, valued...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,875.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the performance location is Conshohocken, PA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $13,675.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The delivery order is for CONTRAVE ER 8-90 MG TABLET 120S and has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is not designated as a set-aside...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CONTRAVE ER 8-90 MG TABLET 120S. The $4,555.98 contract has a completion date of February 6, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this award, which is issued under an indefinite delivery contract (IDC) with a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Contrave ER 8-90 mg tablet 120s. The contract has a ceiling value of $4,549.00 and a period of performance through March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Contrave ER 8-90 mg tablets. The contract, valued at $1,814.81, has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and this award is associated with a $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,351.80 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a potential value of $3,668.60 and a completion date of January 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Contrave ER 8-90 mg tablets in quantities of 120 tablets. The contract has a potential value of $6,095.95 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,250.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3GVDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a potential value of $9,813.88 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is a for-profit organization and the prime contractor on this award. The contract is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 2/21/24 |